Skip to main content

AI Chatbots Can Generate Quality, Empathetic, Readable Responses

Medically reviewed by Carmen Pope, BPharm. Last updated on May 17, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, May 17, 2024 -- For patient questions about cancer, artificial intelligence (AI) chatbots can generate quality, empathetic, and readable responses, according to a study published online May 16 in JAMA Oncology.

David Chen, from the Princess Margaret Hospital Cancer Centre in Toronto, and colleagues examined the competency of AI chatbots (GPT-3.5 [chatbot 1], GPT-4 [chatbot 2], and Claude AI [chatbot 3]) to generate high-quality, empathetic, and readable responses to questions about cancer. AI chatbot responses were compared to responses from six verified oncologists for 200 patient questions about cancer from a public online forum.

The researchers found that compared with physician responses, responses generated by chatbot 3, which was the best-performing AI chatbot, were consistently rated higher in overall measures of quality, empathy, and readability. There was no significant difference noted between the mean Flesch-Kincaid Grade Level of physician responses and chatbot 3 responses (mean, 10.11 versus 10.31); however, the grade level was lower than that seen for chatbot 1 and chatbot 2 (mean, 12.33 and 11.32).

"Further research is required to investigate the implementation of AI chatbots into clinical workflows with consideration of chatbot scope, data security, and content accuracy in the age of digital health care," the authors write.

One author disclosed ties to AstraZeneca Canada.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2024

Read this next

Mortality in Rheumatic Heart Disease Is High

FRIDAY, June 7, 2024 -- Mortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June...

Higher County-Level Prostate Cancer Screening Tied to Better Outcomes

FRIDAY, June 7, 2024 -- Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and...

Metabolic Impact on Offspring Similar for Frozen, Fresh Embryo Transfer

FRIDAY, June 7, 2024 -- For glucose and lipid profiles during early childhood, the impact of frozen embryo transfer (FET) is comparable to that of fresh embryo transfer, according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.